CUV 0.71% $14.09 clinuvel pharmaceuticals limited

epitan - commercialisation contract, page-2

  1. 680 Posts.
    This one is going back to low 20's before long.
    Much has been made up about its prospects but so was SSH and have a look at them now.
    Fact is that Epitan has been promising plenty and delivered little like so many in the medical field.
    They have no earnings, its only a matter of time before they issue more paper .
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.09
Change
0.100(0.71%)
Mkt cap ! $705.3M
Open High Low Value Volume
$14.00 $14.30 $13.93 $676.4K 47.95K

Buyers (Bids)

No. Vol. Price($)
1 200 $14.04
 

Sellers (Offers)

Price($) Vol. No.
$14.16 405 1
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.